79274176 - ORICIRO

Information

  • Trademark
  • 79274176
  • Serial Number
    79274176
  • Registration Number
    6197550
  • Filing Date
    July 23, 2019
    5 years ago
  • Registration Date
    November 17, 2020
    4 years ago
  • Transaction Date
    January 21, 2022
    2 years ago
  • Status Date
    November 17, 2020
    4 years ago
  • Published for Opposition Date
    September 01, 2020
    4 years ago
  • Location Date
    November 17, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    STEDMAN, CORI ALEXA
  • Attorney Docket Number
    20432.108USI
    Attorney Name
    Sandra Epp Ryan
    Law Office Assigned Location Code
    N50
  • Owners
Mark Drawing Code
3000
Mark Identification
ORICIRO
Case File Statements
  • CC0000: The color(s) blue, blue-grey and black is/are claimed as a feature of the mark.
  • CD0000: The colors blue, blue-grey and black are claimed as features of the mark; The mark consists of the waved circle with five convex parts and five concave parts in blue-grey, the waved semicircle with three convex parts and three concave parts in blue and the word "OriCiro" in black.
  • DM0000: The mark consists of a design of a waved circle with five convex parts and five concave parts in blue-grey, interwoven with a waved semicircle with three convex parts and three concave parts in blue to the left of the word "ORICIRO" in black. The color white represents background, outlining, shading, and/or transparent area is not part of the mark.
  • GS0011: Chemical reagents for genetic research, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; reagents for scientific and research use, namely, for DNA amplification; reagents for genetic research purposes, other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; test paper, chemical; reagent paper, other than for medical or veterinary purposes
  • GS0051: Chemical reagents for medical purposes; diagnostic reagents for medical purposes; reagents for use in medical genetic testing; reagents, for medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparations, for the treatment of diseases caused by genetic disorder; reagent paper for medical purposes
  • GS0091: Genetic specimen samplers, other than for medical use, namely, testing sample collection equipment in the nature of wipes and swabs for use in diagnostic testing, not for medical purposes; DNA chips; DNA chip making apparatus being a DNA microarray apparatus; DNA synthesizing apparatus, namely, DNA microarray; DNA analyzing apparatus, namely, laboratory research instruments for DNA analysis; scientific apparatus and instruments and laboratory apparatus for research purposes, namely, polymerase chain reaction thermocyclers used to amplify DNA, for analytical and research purposes; DNA fragmentation apparatus, namely, laboratory apparatus to separate or for breaking DNA strands into pieces; gene testing equipment for research purposes, namely, electrical equipment for the genetic modification of cells for research purposes; analytical apparatus, namely, laboratory apparatus for extracting DNA for use in laboratory; laboratory kits for use with reagents for DNA amplification comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory kits for use with reagents for genetic research comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory apparatus and instruments in the form of kits comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; measuring or testing machines and instruments, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein
  • GS0401: Custom treatment of materials in the nature of syntheses of DNA; custom treatment of materials in the nature of syntheses of RNA; custom treatment of materials in the nature of syntheses of nucleic acids; custom treatment of materials in the nature of amplification of DNA; custom manufacture of chemicals; processing of chemical reagents; processing of medicinal materials, namely, medicinal plants; custom manufacture, namely, extraction, purification and syntheses of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of biopharmaceutical materials by means of DNA engineering; providing material treatment information
  • GS0421: Testing, inspection, research or development services in the fields of genes, namely, research in the fields of genetics, gene therapy, DNA and chemical and biological production methods; consultancy and information services relating to testing, inspection, research or development services in the fields of genes, namely, scientific research consulting in the fields of genetics, gene therapy, DNA and chemical and biological production methods; scientific research in the fields of genetics and genetic engineering; testing, inspection, research or development services in the fields of chemistry, namely, scientific research and development in the fields of chemistry; consultancy and information services relating to testing, inspection, research or development services in the fields of chemistry, namely, chemistry consultation; testing, inspection, research or development services in the fields of pharmaceuticals, namely, testing, inspection, research, or development of pharmaceutical preparations for gene therapy including DNA and RNA-based therapy and vaccines; consultancy and information services relating to testing, inspection, research or development services in the fields of pharmaceuticals, namely, scientific research consulting in the fields of pharmaceuticals; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on prevention of pollution; scientific laboratory services
Case File Event Statements
  • 1/20/2022 - 2 years ago
    26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/20/2022 - 2 years ago
    25 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF
  • 1/20/2022 - 2 years ago
    24 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/20/2022 - 2 years ago
    23 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/21/2021 - 3 years ago
    22 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/26/2021 - 3 years ago
    21 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/26/2021 - 3 years ago
    20 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/17/2021 - 3 years ago
    19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/11/2020 - 4 years ago
    18 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 11/17/2020 - 4 years ago
    17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/1/2020 - 4 years ago
    16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/1/2020 - 4 years ago
    15 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/12/2020 - 4 years ago
    14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/24/2020 - 4 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/23/2020 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/22/2020 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/22/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/8/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/23/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/23/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/24/2019 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/24/2019 - 4 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/23/2019 - 4 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/20/2019 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/20/2019 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 12/19/2019 - 5 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR